DOCSLIB.ORG

221-D100 Controlled Substances Procedures Manual

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Department of Forensic Science COPYRIGHT © 2021 CONTROLLEDVIRGINIA SUBSTANCES PROCEDURESDEPARTMENT MANUAL OF FORENSIC SCIENCE 221-D100 Controlled Substances Procedures Manual Qualtrax ID: 2480 Issued by Chemistry Program Manager UNCONTROLLED Qualtrax Revision 18 Issue Date: 18-August-2021 Page 1 of 176 COPY Table of Contents TABLE OF CONTENTS 1 Introduction 1.1 Introduction 1.2 Examination Documentation 2 Analytical Schemes 2.1 Introduction 2.2 Determination of Quantity 2.3 General Unknowns/Powders/Illicit Tablets 2.4 Tablets and Capsules 2.5 Cannabis 2.6 Pharmaceutical Identifiers 2.7 Color Tests 2.8 Chromatography 2.9 Infrared Spectroscopy/MassCOPYRIGHT Spectrometry © 2021 2.10 Further Testing 2.11 Liquids 2.12 Plant Material 3 Drug Item Reduction Program VIRGINIA 3.1 Introduction DEPARTMENT 3.2 Procedures 4 Weighing Practices OF 4.1 Procedures FORENSIC SCIENCE 4.2 Weighing Practices 4.3 References 5 Sampling 5.1 Introduction 5.2 General Sampling 5.3 Administrative Sampling Plan 5.4 Hypergeometric Sampling Plan 5.5 Multiple Specimens 5.6 Bulk Materials 5.7 Residue Samples 5.8 Sampling for Quantitative Analysis 5.9 References 6 Cannabis Plant Material 6.1 Introduction 6.2 Macroscopic Identification 6.3 Microscopic Identification 6.4 4-Aminophenol (4-AP) Color Test 6.5 Duquenois-Levine 6.6 Thin Layer Chromatography (TLC) 6.7 DART-TOF 6.8 Semi-quantitative Gas Chromatography-Flame Ionization-Mass Spectrometry (GC-FID-MS) 6.9 Quantitative Analysis of Total THC in Plant Material using GC/MS (SIM) 6.10 Residues 221-D100 Controlled Substances Procedures Manual Qualtrax ID: 2480 Issued by Chemistry Program Manager UNCONTROLLED Qualtrax Revision 18 Issue Date: 18-August-2021 Page 2 of 176 COPY Table of Contents 6.11 References 7 Cannabis Extracts and Products 7.1 Introduction 7.2 Cannabis Extracts 7.3 Extraction of THC from Food Products (candy, brownies, etc.) 7.4 Cannabinoid Quantitation by High Performance Liquid Chromatography – Diode Array Detection (HPLC-DAD) 7.5 References 8 Pharmaceutical Identifiers (PI) 8.1 Introduction 8.2 Procedure 9 Color Tests COPYRIGHT © 2021 9.1 Introduction 9.2 Procedures 9.3 Color Tests and Reagents 9.4 References VIRGINIA 10 Thin Layer Chromatography DEPARTMENT 10.1 Introduction 10.2 Materials 10.3 Methods OF 10.4 TLC Baths 10.5 Visualization ReagentsFORENSIC SCIENCE 10.6 Preparative Thin Layer Chromatography 10.7 Comparative Semi-Quantitative Thin Layer Chromatography 10.8 References 11 Gas Chromatography 11.1 Introduction 11.2 Materials 11.3 Methods 11.4 Quantitation 12 High Performance Liquid Chromatography (HPLC) 12.1 Introduction 12.2 Materials 12.3 Methods 12.4 Quantitation 13 Analysis of Pharmaceutical Injectable Dosage Forms 13.1 Introduction 13.2 Procedure 13.3 Reporting 14 Infrared Spectroscopy 14.1 Introduction 221-D100 Controlled Substances Procedures Manual Qualtrax ID: 2480 Issued by Chemistry Program Manager UNCONTROLLED Qualtrax Revision 18 Issue Date: 18-August-2021 Page 3 of 176 COPY Table of Contents 14.2 Sample Preparation 14.3 Solid State FTIR via Gas Chromatography 14.4 Acceptance Criteria 15 Gas Chromatography/Mass Spectrometry 15.1 Introduction 15.2 Procedure 15.3 Data Interpretation and Acceptance Criteria 16 DART-TOF Mass Spectrometry 16.1 Introduction 16.2 General Drug Screening Method 16.3 Negative Screening Method including GHB 16.4 Pharmaceutical Confirmation via DART-TOF 16.5 References COPYRIGHT © 2021 17 General Analytical Methodology 17.1 Introduction 17.2 Techniques VIRGINIA 17.3 Reference Collections 17.4 Structural Similarity EvaluationDEPARTMENT 17.5 Guidelines for Quantitative Method Validation and Verification 18 Stimulant Methodology OF 18.1 Brief PharmacologyFORENSIC SCIENCE 18.2 Drug Group Examples 18.3 Types of Samples 18.4 Scheduling 18.5 Extraction 18.6 Color Test Results 18.7 TLC 18.8 GC 18.9 GC/MS 18.10 FTIR 18.11 Amphetamine/Methamphetamine Quantitation 18.12 Differentiation of the Stereoisomers of Methamphetamine using GC Derivatization (Determination of “ICE”) 19 Cocaine and Local Anesthetic Methodology 19.1 Brief Pharmacology 19.2 Drug Group Examples 19.3 Scheduling 19.4 Extraction 19.5 Color Test Results 19.6 TLC 19.7 FTIR 19.8 Cocaine Quantitation 20 Barbiturate Methodology 20.1 Brief Pharmacology 221-D100 Controlled Substances Procedures Manual Qualtrax ID: 2480 Issued by Chemistry Program Manager UNCONTROLLED Qualtrax Revision 18 Issue Date: 18-August-2021 Page 4 of 176 COPY Table of Contents 20.2 Drug Group Examples 20.3 Types of Samples 20.4 Scheduling 20.5 Extraction 20.6 Color Test Results 20.7 TLC 20.8 GC 20.9 GC/MS 20.10 FTIR 21 Narcotic Methodology 21.1 Brief Pharmacology 21.2 Drug Group Examples 21.3 Scheduling 21.4 Extraction 21.5 Color Test Results 21.6 TLC COPYRIGHT © 2021 21.7 Dextromethorphan Enantiomer Determination 21.8 Heroin Quantitation 22 Phencyclidine (PCP) and Analog MethodologyVIRGINIA 22.1 Brief Pharmacology 22.2 Scheduling DEPARTMENT 22.3 Extraction 22.4 Color Test Results 22.5 TLC OF 22.6 GC 22.7 FTIR FORENSIC SCIENCE 22.8 PCP Quantitation 23 Lysergic Acid Diethylamide (LSD) Methodology 23.1 Scheduling 23.2 Analog 23.3 Extraction 23.4 Color Test Results 23.5 TLC 23.6 GC 23.7 FTIR 24 Mescaline Methodology 24.1 Scheduling 24.2 Extraction 24.3 Color Test Results 24.4 TLC 25 Psilocybin and Psilocyn Methodology 25.1 Scheduling 25.2 Extractions 25.3 Color Test Results 25.4 TLC 25.5 GC 25.6 FTIR 221-D100 Controlled Substances Procedures Manual Qualtrax ID: 2480 Issued by Chemistry Program Manager UNCONTROLLED Qualtrax Revision 18 Issue Date: 18-August-2021 Page 5 of 176 COPY Table of Contents 26 Cathinone Methodology 26.1 Scheduling 26.2 Sample Handling 26.3 Extraction 26.4 TLC 26.5 GC/MS 26.6 References 27 MDA/MDMA Methodology 27.1 Scheduling 27.2 Color Test Results 27.3 TLC 27.4 GC 27.5 FTIR 27.6 MDMA QuantitationCOPYRIGHT © 2021 28 Anabolic Steroid Methodology 28.1 Brief Pharmacology 28.2 Drug Group Examples VIRGINIA 28.3 Scheduling 28.4 Extraction DEPARTMENT 28.5 Color Test Results 28.6 Pharmaceutical Identifiers 28.7 TLC OF 28.8 GC 28.9 FTIR FORENSIC SCIENCE 28.10 GC/MS 28.11 References 29 GHB Methodology 29.1 Brief Pharmacology 29.2 Drug Group Examples 29.3 Scheduling 29.4 Chemical Properties 29.5 pH 29.6 Color Test Results 29.7 TLC 29.8 GC 29.9 GC/MS 29.10 FTIR 29.11 References 30 Salvinorin A Methodology 30.1 Scheduling 30.2 Extractions 30.3 TLC 30.4 GC and GC/MS 30.5 Reporting 30.6 References 31 Cannabimimetic Agent Methodology 221-D100 Controlled Substances Procedures Manual Qualtrax ID: 2480 Issued by Chemistry Program Manager UNCONTROLLED Qualtrax Revision 18 Issue Date: 18-August-2021 Page 6 of 176 COPY Table of Contents 31.1 Scheduling 31.2 Extractions 31.3 TLC 31.4 GC and GC/MS 31.5 References 32 Clandestine Laboratories 32.1 Introduction 32.2 Analytical Approach 32.3 Procedure 32.4 References 33 Estimation of the Uncertainty of Measurement (UoM) 33.1 Scope 33.2 Uncertainty ElementsCOPYRIGHT © 2021 33.3 Weights 33.4 Determination of Uncertainty of Measurement for Extrapolation Cases 33.5 Case File Records and Reporting for Weights 33.6 Measurement Traceability 33.7 Quantitations VIRGINIA 33.8 References DEPARTMENT 34 Reporting Guidelines 35 Drug Reversals OF 35.1 Introduction FORENSIC SCIENCE 35.2 Procedure 36 Quality Assurance 36.1 Introduction 36.2 Reagents 36.3 Standards 36.4 Balances 36.5 Thin Layer Chromatography 36.6 Gas Chromatographs 36.7 Liquid Chromatographs 36.8 Mass Spectrometers 36.9 FTIR 36.10 DART-TOF 36.11 Refrigerators/Freezers 36.12 DiscovIR GC-FTIR 36.13 Glassware 36.14 Mechanical Pipettes 37 Bibliography 38 Scheduling 38.1 Schedule I 38.2 Schedule II 38.3 Schedule III 38.4 Schedule IV 221-D100 Controlled Substances Procedures Manual Qualtrax ID: 2480 Issued by Chemistry Program Manager UNCONTROLLED Qualtrax Revision 18 Issue Date: 18-August-2021 Page 7 of 176 COPY Table of Contents 38.5 Schedule V 38.6 Schedule VI 39 Weight Thresholds 40 Hypergeometric Table 41 Commonly Used Abbreviations COPYRIGHT © 2021 VIRGINIA DEPARTMENT OF FORENSIC SCIENCE 221-D100 Controlled Substances Procedures Manual Qualtrax ID: 2480 Issued by Chemistry Program Manager UNCONTROLLED Qualtrax Revision 18 Issue Date: 18-August-2021 Page 8 of 176 COPY 1 Introduction 1 INTRODUCTION 1.1 Introduction The information in this Procedures Manual was collected from numerous sources and is presented here for easy reference for drug chemists. In all cases, it is acceptable to use the most current edition of listed literature references. This manual presents a basic outline of the types of drugs analyzed, a source book on reagent and standard preparation and a description of the analytical techniques used with a review of instrumentation. This manual is not all-inclusive, and will reference other sources where appropriate. It is always the chemist's responsibility to choose the best analytical scheme for each individual case. It is expected that supervisors will be consulted for extraordinary procedures. 1.2 Examination Documentation 1.2.1 Specific worksheets are provided as controlled forms and should be used as designed. Examination documentation must contain sufficient detail to allow another examiner to repeat the analysis under conditions as close as possible to the original, evaluate the data, interpret the results and come to the same conclusion. COPYRIGHT © 2021 1.2.2 The General Drug Worksheet is a generic worksheet for controlled substances casework. The comments section should be used for explanations of tests or lists of weights, etc. 1.2.3 The Blank Worksheet is availableVIRGINIA for cases requiring more notes than will easily fit on the General Drug Worksheet.
Recommended publications
  • Recommended Methods for the Identification and Analysis of Synthetic Cathinones in Seized Materialsd

    Recommended Methods for the Identification and Analysis of Synthetic Cathinones in Seized Materialsd

    Recommended methods for the Identification and Analysis of Synthetic Cathinones in Seized Materials (Revised and updated) MANUAL FOR USE BY NATIONAL DRUG ANALYSIS LABORATORIES Photo credits:UNODC Photo Library; UNODC/Ioulia Kondratovitch; Alessandro Scotti. Laboratory and Scientific Section UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna Recommended Methods for the Identification and Analysis of Synthetic Cathinones in Seized Materials (Revised and updated) MANUAL FOR USE BY NATIONAL DRUG ANALYSIS LABORATORIES UNITED NATIONS Vienna, 2020 Note Operating and experimental conditions are reproduced from the original reference materials, including unpublished methods, validated and used in selected national laboratories as per the list of references. A number of alternative conditions and substitution of named commercial products may provide comparable results in many cases. However, any modification has to be validated before it is integrated into laboratory routines. ST/NAR/49/REV.1 Original language: English © United Nations, March 2020. All rights reserved, worldwide. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. Mention of names of firms and commercial products does not imply the endorse- ment of the United Nations. This publication has not been formally edited. Publishing production: English, Publishing and Library Section, United Nations Office at Vienna. Acknowledgements The Laboratory and Scientific Section of the UNODC (LSS, headed by Dr. Justice Tettey) wishes to express its appreciation and thanks to Dr.
  • William Prince

    William Prince

    William Prince by Ted A Griffin Table Of Contents Register Report for William Prince 1 Kinship Report for William Prince 76 Index 102 ii Register Report for William Prince Generation 1 1. WILLIAM1 PRINCE was born about 1788 in Candys Creek, Mcminniville, Tennessee, USA. He died in 1850 in Lawrence, Kentucky, United States. He married (1) LAURIE FYFFE in 1798. He married (2) RACHEL MURPHY about 1810 in Russell, Virginia, USA. She was born about 1784 in Tennessee, USA. She died in Lawrence, Kentucky, United States. Notes for William Prince: We know that William Prince was named William D. Prince as the 1850 census of Habersham county shows this, and also the 1850 delinquent tax list of Habersham shows the same name. The 1850 Murray county GA census shows William enumerated without his middle initial, but there is no doubt it is the same family (with a few unsurprising discrepancys) that appears in 1850 Habersham. As Joseph Prince owned land in Murray county GA in 1850, it is certainly likely that William was residing on that land once he left Habersham. (Phil Prince <[email protected]>) Notes for Laurie Fyffe: There is no evidence that this is correct. It is most likely that Laurie Fyffe married some other William Prince. Notes for Rachel Murphy: Rachel filed for divorce on Dec 21, 1835 stating that she and William had moved back to Lawrence Co. abt 1828 and in 1829 he had deserted her and taken up with Arty Mullins. (According to my Great Aunt Emma Prince Thompson, Carter Prince's Grandmother was a Gregor.
  • CBD (Cannabidiol)

    CBD (Cannabidiol)

    TRANSPORTATION RESEARCH BOARD Driving Toward the Truth - Dispelling the Myths About Cannabis Products February 10, 2021 @NASEMTRB #TRBwebinar PDH Certification The Transportation Research Board has met the standards and Information: requirements of the Registered Continuing Education Providers •1.5 Professional Development Program. Credit earned on completion Hour (PDH) – see follow-up of this program will be reported to email for instructions RCEP. A certificate of completion will •You must attend the entire be issued to participants that have registered and attended the entire webinar to be eligible to receive session. As such, it does not include PDH credits content that may be deemed or •Questions? Contact Reggie construed to be an approval or Gillum at [email protected] endorsement by RCEP. #TRBwebinar Learning Objectives 1. Identify impacts of the Farm Bill on use of THC and CBD products 2. Describe the toxicology of THC and CBD products 3. Discuss how THC and CBD products affect driving performance and crash risk #TRBwebinar TRB Standing Committee on Impairment in Transportation (ACS50) TRB Webinar: Driving Toward the Truth - Dispelling the Myths About Cannabis Products Dr. Barry K. Logan Executive Director, Center for Forensic Science Research and Education (CFSRE); Senior Vice President of Forensic Sciences, and Chief Scientist at NMS Labs Michelle Peace, Ph.D. Associate Professor and PI, Laboratory for Forensic Toxicology Research Department of Forensic Science, Virginia Commonwealth University Dr. Darrin Grondel Vice President,
  • Moves to Amend HF No. 2128 As Follows:​ Delete Everything After

    Moves to Amend HF No. 2128 As Follows:​ Delete Everything After

    04/05/21 10:32 am ​ HOUSE RESEARCH RC/MV H2128DE1​ 1.1 .................... moves to amend H.F. No. 2128 as follows:​ 1.2 Delete everything after the enacting clause and insert:​ 1.3 "ARTICLE 1​ 1.4 DHS HEALTH CARE PROGRAMS​ 1.5 Section 1. [62A.002] APPLICABILITY OF CHAPTER.​ 1.6 Any benefit or coverage mandate included in this chapter does not apply to managed​ 1.7 care plans or county-based purchasing plans when the plan is providing coverage to state​ 1.8 public health care program enrollees under chapter 256B or 256L.​ 1.9 Sec. 2. Minnesota Statutes 2020, section 62C.01, is amended by adding a subdivision to​ 1.10 read:​ 1.11 Subd. 4. Applicability. Any benefit or coverage mandate included in this chapter does​ 1.12 not apply to managed care plans or county-based purchasing plans when the plan is providing​ 1.13 coverage to state public health care program enrollees under chapter 256B or 256L.​ 1.14 Sec. 3. Minnesota Statutes 2020, section 62D.01, is amended by adding a subdivision to​ 1.15 read:​ 1.16 Subd. 3. Applicability. Any benefit or coverage mandate included in this chapter does​ 1.17 not apply to managed care plans or county-based purchasing plans when the plan is providing​ 1.18 coverage to state public health care program enrollees under chapter 256B or 256L.​ 1.19 Sec. 4. [62J.011] APPLICABILITY OF CHAPTER.​ 1.20 Any benefit or coverage mandate included in this chapter does not apply to managed​ 1.21 care plans or county-based purchasing plans when the plan is providing coverage to state​ 1.22 public health care program enrollees under chapter 256B or 256L.​ Article 1 Sec.
  • What Is Delta-8 THC?? Cannabinoid Chemistry 101

    What Is Delta-8 THC?? Cannabinoid Chemistry 101

    What is Delta-8 THC?? Cannabinoid Chemistry 101 National Conference on Weights and Measures Annual Meeting - Rochester, NY Matthew D. Curran, Ph.D. July 21, 2021 Disclaimer Just to be clear… • I am a chemist and not a lawyer so: • This presentation will not discuss the legal aspects of Δ8-THC or DEA’s current position. • This presentation will not discuss whether Δ8-THC is considered “synthetic” or “naturally occurring.” • This is not a position statement on any issues before the NCWM. • Lastly, this should only be considered a scientific sharing exercise. Florida Department of Agriculture and Consumer Services 2 Cannabis in Florida Cannabis Syllabus • What is Cannabis? • “Mother” Cannabinoid • Decarboxylation • Relationship between CBD and THC • What does “Total” mean? • Dry Weight vs. Wet Weight • What does “Delta-9” mean? • Relationship between “Delta-8” and “Delta-9” • CBD to Delta-8 THC • Cannabinoid Chemistry 202… Florida Department of Agriculture and Consumer Services 3 Cannabis Cannabis • Cannabis sativa is the taxonomic name for the plant. • The concentration of Total Δ9-Tetrahydrocannabinol (Total Δ9-THC) is critical when considering the varieties of Cannabis sativa. • Hemp – (Total Δ9-THC) 0.3% or less • Not really a controversial term, “hemp” • Marijuana/cannabis – (Total Δ9-THC) Greater than 0.3% • Controversial term, “marijuana” • Some states prohibit the use of this term whereas some states have it in their laws. • Some states use the term “cannabis.” • Not italicized • Lower case “c” Florida Department of Agriculture and
  • In Silico Assessment of Drug-Like Properties of Phytocannabinoids in Cannabis Sativa

    In Silico Assessment of Drug-Like Properties of Phytocannabinoids in Cannabis Sativa

    EDUCATUM JSMT Vol. 4 No. 2 (2017) ISSN 2289-7070 / eISSN 2462-2451 (1-7) https://ejournal.upsi.edu.my/journal/EDSC In Silico Assessment of Drug-Like Properties of Phytocannabinoids in Cannabis Sativa Shakinaz Desa1*, Asiah Osman2, and Richard Hyslop3 1Department of Biology, Universiti Pendidikan Sultan Idris, Malaysia, 2Natural Product Division, Forest Research Institute Malaysia, 3Department of Chemistry and Biochemistry, University of Northern Colorado, USA *Corresponding author: [email protected] Abstract This study investigated drug-like properties of phytocannabinoids in Cannabis sativa using an in silico study. We report sixteen phytocannabinoids: cannabidiol (CBD), cannabidiolic acid (CBDA), cannabinol (CBN), cannabichromene (CBC), cannabigerol (CBG), cannabicyclol (CBL), cannabivarin (CBV), cannabidivarin (CBDV), cannabichromevarin (CBCV), cannabigerovarin (CBGV), cannabinodiol (CBDL), cannabielsoin (CBE), cannabitriol (CBT), Δ9-tetrahydrocannabinol (Δ9-THC), Δ9-tetrahydrocannabivarin (Δ9-THCV), and Δ8-tetrahydrocannabinol (Δ8-THC). All chemical structures and properties were obtained from PubChem Compound, National Center for Biotechnology Information, U.S. National Library of Medicine. Molinspiration was used for the calculation of molecular properties and bioactivity score. The parameters were molecular weight (MW), number of hydrogen acceptor (HBA), number of hydrogen donor (HBD), partition coefficient (cLogP), polar surface area (PSA) and number of rotatable bonds (NROTB). We predicted bioactivity scores for G Protein-Coupled Receptors (GPCR) ligand, ion channel modulator, kinase inhibitor, nuclear receptor ligand, protease inhibitor and enzyme inhibitor. Lipinski’s rule was used as reference to determine the drug-like properties of the phytocannabinoids. All compounds have MW<500, HBA<10, HBD<5, TPSA<140Å2 and NRTOB<10. Bioactivity score showed an active or moderately active in all compounds.
  • Fragmentation Pathways of Odd- and Even-Electron N-Alkylated Synthetic Cathinones

    Fragmentation Pathways of Odd- and Even-Electron N-Alkylated Synthetic Cathinones

    International Journal of Mass Spectrometry 453 (2020) 116354 Contents lists available at ScienceDirect International Journal of Mass Spectrometry journal homepage: www.elsevier.com/locate/ijms Fragmentation pathways of odd- and even-electron N-alkylated synthetic cathinones * J. Tyler Davidson, PhD a, Zachary J. Sasiene, BS b, Glen P. Jackson, Ph.D. a, b, a Department of Forensic and Investigative Science, West Virginia University, Morgantown, WV, 26506-6121, USA b C. Eugene Bennett Department of Chemistry, West Virginia University, Morgantown, WV, 26506-6121, USA article info abstract Article history: Three ionization techniques, isotopic labeling, high-resolution mass spectrometry (HRMS) and multi- Received 19 March 2020 stage mass spectrometry (MSn) were used to analyze a series of N-alkylated synthetic cathinone de- Received in revised form rivatives and gain a deeper understanding of their fragmentation behavior during mass spectrometric 17 April 2020 analysis. The compounds analyzed represent 15 unique structures with common substitutions to the core Accepted 18 April 2020 synthetic cathinone structure, including substitutions to the aromatic ring and the number and types of Available online 23 April 2020 N-alkyl functionalities. The analytical techniques employed include gas chromatography-electron ioni- zation-mass spectrometry (GC-EI-MS), electrospray ionization-tandem mass spectrometry (ESI-MS/MS) with HRMS and direct analysis in real time tandem mass spectrometry (DART-MS/MS) with HRMS. These techniques cover a variety of forensic applications, including seized drug analysis, toxicological analysis and screening analysis, in local, state and federal laboratories. For collision-induced dissociation (CID) of protonated precursors, the spectra of 2 and 3 amines showed evidence for charge-remote and charge- directed fragmentation mechanisms.
  • Charleston Orphan House Index, 1796-1929

    Charleston Orphan House Index, 1796-1929

    Charleston Orphan House Index, 1796-1929 Name of Orphan Date Parents/Guardians Other Persons Indentured to Whom Trade/Relation Other Filed Cameron, Mary 1796 Thorne, Sarah mantuamaker IND Walters, Thomas 1796 Oliphant, David painter IND Anderson, Ann 1797 Anderson, John and Maria AA Anderson, Charlotte 1797 Anderson, John and Maria AA Anderson, Jonathan 1797 Anderson, John and Maria AA Anderson, Margaret 1797 Anderson, John and Maria AA Anderson, Robert 1797 Anderson, John and Maria AA Brown, John 1800 Brown, Thomas AA Calvert, John 1800 Keowin, F. AA Calvert, William 1800 Keowin, F. AA Rosenbohm, Catharine 1801 Carrere, Catherine E. needleworker IND Anderson, Jonathan 1802 Horlbeck, George coachmaker RIND Anonymous 1802 Arms, Elizabeth mantuamaker RIND Anonymous 1802 Yoer, Jacob shoemaker RIND Baker, Susan 1802 Gallaway, Elizabeth mantuamaker RIND Barry, James 1802 Barry, James father IND Connors, John 1802 Yoer, Jacob shoemaker RIND Ford, Ann 1802 Pearson, Frances A. R. domestic IND Ford, Nancy 1802 Sibley, Ann RIND Hughes, Edward Henry 1802 Maull, Henry half-brother IND Jones, Edward 1802 Jones, Edward Smith, William AA Jones, John 1802 Jones, Edward Smith, William AA Jones, Joseph 1802 Jones, Edward Smith, William AA Kingdon, Henry 1802 Horlbeck, George coachmaker RIND Mahoney, Mary 1802 Fuller, Christopher domestic IND Mahoney, Polly 1802 Bonnetheau, Martha IND Maxey, Ann 1802 Maxey, Ann Purcell, Joseph AA Maxey, Elizabeth 1802 Maxey, Ann Purcell, Joseph AA McNeal, Harriot 1802 McNeal, Elizabeth AA McNeal, Henry 1802 McNeal, Elizabeth AA O'Keefe, Thomas 1802 Horlbeck, George coachmaker RIND Randall, Ann 1802 Gilchrist, Adam RAA Remley, Henry 1802 Yoer, Jacob shoemaker RIND Smith, Elizabeth 1802 Purcell, Joseph AA Spence, William 1802 Cunningham and O'Neale merchant IND Suder, Charlotte 1802 Long, Mary domestic IND Symonds, Charles 1802 Gantt, Esther AA Withers, two children 1802 Withers, Mrs.
  • Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances Joshua Zolton Seither Jseit005@Fiu.Edu

    Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances Joshua Zolton Seither [email protected]

    Florida International University FIU Digital Commons FIU Electronic Theses and Dissertations University Graduate School 4-25-2018 Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances Joshua Zolton Seither [email protected] DOI: 10.25148/etd.FIDC006565 Follow this and additional works at: https://digitalcommons.fiu.edu/etd Part of the Chemistry Commons Recommended Citation Seither, Joshua Zolton, "Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances" (2018). FIU Electronic Theses and Dissertations. 3823. https://digitalcommons.fiu.edu/etd/3823 This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact [email protected]. FLORIDA INTERNATIONAL UNIVERSITY Miami, Florida APPLICATION OF HIGH RESOLUTION MASS SPECTROMETRY FOR THE SCREENING AND CONFIRMATION OF NOVEL PSYCHOACTIVE SUBSTANCES A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in CHEMISTRY by Joshua Zolton Seither 2018 To: Dean Michael R. Heithaus College of Arts, Sciences and Education This dissertation, written by Joshua Zolton Seither, and entitled Application of High- Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances, having been approved in respect to style and intellectual content, is referred to you for judgment. We have read this dissertation and recommend that it be approved. _______________________________________ Piero Gardinali _______________________________________ Bruce McCord _______________________________________ DeEtta Mills _______________________________________ Stanislaw Wnuk _______________________________________ Anthony DeCaprio, Major Professor Date of Defense: April 25, 2018 The dissertation of Joshua Zolton Seither is approved.
  • Written Witness Statement for U.S. Sentencing Commission's Public

    Written Witness Statement for U.S. Sentencing Commission's Public

    STATEMENT OF TERRENCE L. BOOS, PH.D. SECTION CHIEF DRUG AND CHEMICAL EVALUATION SECTION DIVERSION CONTROL DIVISION DRUG ENFORCEMENT ADMINISTRATION and CASSANDRA PRIOLEAU, PH.D. DRUG SCIENCE SPECIALIST DRUG AND CHEMICAL EVALUATION SECTION DIVERSION CONTROL DIVISION DRUG ENFORCEMENT ADMINISTRATION - - - BEFORE THE UNITED STATES SENTENCING COMMISSION - - - HEARING ON SENTENCING POLICY FOR SYNTHETIC DRUGS - - - OCTOBER 4, 2017 WASHINGTON, D.C. 1 Introduction New Psychoactive Substances (NPS) are substances trafficked as alternatives to well- studied controlled substances of abuse. NPS have demonstrated adverse health effects such as paranoia, psychosis, and seizures to name a few. Cathinones, cannabinoids, and fentanyl-related substances are the most common NPS drug classes encountered on the illicit drug market, all with negative consequences for the user to include serious injury and death. Our early experience saw substances being introduced from past research efforts in an attempt to evade controls. This has evolved to NPS manufacturers structurally altering substances at a rapid pace with unknown outcomes to targeting specific user populations. These substances represent an unprecedented level of diversity and consequences. Due to clandestine manufacture and unscrupulous trafficking, the user is at great risk. A misconception exists that these substances carry a lower risk of harm In reality, published reports from law enforcement, emergency room physicians and scientists, accompanied with autopsies from medical examiners, have clearly demonstrated the harmful and potentially deadly consequences of using synthetic cathinones. These substances are introduced in an attempt to circumvent drug controls and the recent flood of NPS remains a challenge for law enforcement and public health. The United Nations Office on Drugs and Crime reported over 700 NPS encountered.1 The manufacturers and traffickers make minor changes in the chemical structure of known substances of abuse and maintain the pharmacological effect.
  • Model Scheduling New/Novel Psychoactive Substances Act (Third Edition)

    Model Scheduling New/Novel Psychoactive Substances Act (Third Edition)

    Model Scheduling New/Novel Psychoactive Substances Act (Third Edition) July 1, 2019. This project was supported by Grant No. G1799ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the Office of National Drug Control Policy or the United States Government. © 2019 NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. This document may be reproduced for non-commercial purposes with full attribution to the National Alliance for Model State Drug Laws. Please contact NAMSDL at [email protected] or (703) 229-4954 with any questions about the Model Language. This document is intended for educational purposes only and does not constitute legal advice or opinion. Headquarters Office: NATIONAL ALLIANCE FOR MODEL STATE DRUG 1 LAWS, 1335 North Front Street, First Floor, Harrisburg, PA, 17102-2629. Model Scheduling New/Novel Psychoactive Substances Act (Third Edition)1 Table of Contents 3 Policy Statement and Background 5 Highlights 6 Section I – Short Title 6 Section II – Purpose 6 Section III – Synthetic Cannabinoids 13 Section IV – Substituted Cathinones 19 Section V – Substituted Phenethylamines 23 Section VI – N-benzyl Phenethylamine Compounds 25 Section VII – Substituted Tryptamines 28 Section VIII – Substituted Phenylcyclohexylamines 30 Section IX – Fentanyl Derivatives 39 Section X – Unclassified NPS 43 Appendix 1 Second edition published in September 2018; first edition published in 2014. Content in red bold first added in third edition. © 2019 NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. This document may be reproduced for non-commercial purposes with full attribution to the National Alliance for Model State Drug Laws.
  • A Grounded Theory Analysis of Civil and Administrative Cases Pursued by the Security and Exchange Commission

    A Grounded Theory Analysis of Civil and Administrative Cases Pursued by the Security and Exchange Commission

    A GROUNDED THEORY ANALYSIS OF CIVIL AND ADMINISTRATIVE CASES PURSUED BY THE SECURITY AND EXCHANGE COMMISSION ___________ A Thesis Presented to The Faculty of the Department of Criminal Justice and Criminology Sam Houston State University ___________ In Partial Fulfillment of the Requirements for the Degree of Master of Arts ___________ by Matthew Caines August, 2021 A GROUNDED THEORY ANALYSIS OF CIVIL AND ADMINISTRATIVE CASES PURSUED BY THE SECURITY AND EXCHANGE COMMISSION by Matthew Caines ___________ APPROVED: Jurg Gerber, PhD Committee Director Elisa Toman, PhD Committee Member Mitchel Roth, PhD Committee Member Phillip Lyons, PhD Dean, College of Criminal Justice ABSTRACT Caines, Matthew, A grounded theory analysis of civil and administrative cases pursued by the Security and Exchange Commission. Master of Arts (Criminal Justice and Criminology) August, 2021, Sam Houston State University, Huntsville, Texas. In the midst of the Great Depression in the 1930s, the government took considerable actions in an attempt to control the questionable and troubling practices of business to help prevent a similar crisis from ever burdening the nation again. What it created was the Securities and Exchange Commission (“SEC”), which today continues to bear primary responsibility for the administration of securities laws and enforcement actions against violators. Moreover, the SEC has increasingly gained enforcement capacities over its lifespan. Today, it can not only impose professional bars on violators, but also force them to forfeit any ill-gotten gains and even pay monetary fines through civil and administrative proceedings. While not conventionally thought of as criminal, these white-collar offenses can have a tremendous and harmful impact on their victims and the larger market.